Trials / Conditions / Malignant Mesothelioma (MM)
Malignant Mesothelioma (MM)
4 registered clinical trials studyying Malignant Mesothelioma (MM) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma NCT06654050 | National Cancer Institute (NCI) | Phase 2 |
| Not Yet Recruiting | Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors NCT07282873 | TYK Medicines, Inc | Phase 1 / Phase 2 |
| Suspended | Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition NCT05960773 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors NCT05563272 | Telix Pharmaceuticals (Innovations) Pty Ltd | Phase 2 |